Hanna Cho, MD, PhD
To reduce the scale and impact of dementia, we need to advance our knowledge of mechanisms about dementia by developing optimal biomarkers to detect and track disease, and to establish implementation of treatment of dementia.
As an medical doctor with a strong clinical focus and proven research track record on dementia, Hanna's scope of work is based on more than 10 years of clinical experience and extensive research involving dementia and cognitive impairment. She also has a keen interest in contributing more to society and health policy issues to improve brain health.
Dr. Duk L. Na, Dr. CH Lyoo, and my father
Words of Strength
passion, positive attitude, sincerity, consistency, and warmth
To reduce the scale and impact of dementia, Hanna believes we need to advance our knowledge of mechanisms about dementia by developing optimal biomarkers to detect and track disease, and to establish implementation of treatment of dementia.
Interests of Hanna's professional achievements include a research topic focused on amyloid and tau PET imaging in dementia patients. These two biomarkers complement each other and will expand the role of biomarkers from screening to treatment of AD.
Hanna will not only deepen her knowledge and experience as a doctor and neurologist, but she will also extend the boundaries of her disciplinary perceptions to shape inter-disciplinary prevention and intervention.
South Korea, known for its breakneck speed economic development as well as one of the world’s fastest aging populations, is emerging as a country with the biggest social problem with the rapid increase in dementia population along with low birth rates.
Dr. Cho is an Associate Professor, Department of Neurology, Gangnam Severance Hospital, Yonsei University, Seoul, Republic of Korea. She received her MD and PhD from Yonsei University College of Medicine. She completed an internship, neurology residency at Yonsei University and a behavioral and dementia neurology fellowship at the Samsung Medical Center.